- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients ; volume:18 ; number:1 ; day:20 ; month:2 ; year:2018 ; pages:1-4 ; date:12.2018
BMC ophthalmology ; 18, Heft 1 (20.2.2018), 1-4, 12.2018
- Keyword
-
Augenheilkunde
Augenkrankheit
- Creator
-
Lee, Ji Hwan
- Contributor
-
Lee, Christopher Seungkyu
Lee, Sung Chul
SpringerLink (Online service)
- DOI
-
10.1186/s12886-018-0719-0
- URN
-
urn:nbn:de:1111-2018041527425
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Ji Hwan
- Lee, Christopher Seungkyu
- Lee, Sung Chul
- SpringerLink (Online service)
Other Objects (12)
A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome
Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
Decreased interleukin 27 expression is associated with active uveitis in Behçet’s disease
Decoding Behcet’s Uveitis: an In-depth review of pathogenesis and therapeutic advances
Sex-specific circulating unconventional neutrophils determine immunological outcome of auto-inflammatory Behçet’s uveitis
Cataract surgery combined with micro-incision vitrectomy in patients with behcet’s disease uveitis
Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents
Quantitative urinary proteome analysis reveals potential biomarkers for disease activity of Behcet’s disease uveitis
Association between subfoveal choroidal thickness and leakage site on fluorescein angiography in Behçet’s uveitis
Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet’s disease
Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet’s disease-related uveitis
Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome
A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome
Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
Decreased interleukin 27 expression is associated with active uveitis in Behçet’s disease
Decoding Behcet’s Uveitis: an In-depth review of pathogenesis and therapeutic advances
Sex-specific circulating unconventional neutrophils determine immunological outcome of auto-inflammatory Behçet’s uveitis
Cataract surgery combined with micro-incision vitrectomy in patients with behcet’s disease uveitis
Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents
Quantitative urinary proteome analysis reveals potential biomarkers for disease activity of Behcet’s disease uveitis
Association between subfoveal choroidal thickness and leakage site on fluorescein angiography in Behçet’s uveitis
Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet’s disease
Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet’s disease-related uveitis
Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome
A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome
Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
Decreased interleukin 27 expression is associated with active uveitis in Behçet’s disease
Decoding Behcet’s Uveitis: an In-depth review of pathogenesis and therapeutic advances
Sex-specific circulating unconventional neutrophils determine immunological outcome of auto-inflammatory Behçet’s uveitis
Cataract surgery combined with micro-incision vitrectomy in patients with behcet’s disease uveitis
Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents
Quantitative urinary proteome analysis reveals potential biomarkers for disease activity of Behcet’s disease uveitis
Association between subfoveal choroidal thickness and leakage site on fluorescein angiography in Behçet’s uveitis
Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet’s disease
Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet’s disease-related uveitis